Pedro Gonzalez‐Alegre

3.4k total citations
85 papers, 2.0k citations indexed

About

Pedro Gonzalez‐Alegre is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Pedro Gonzalez‐Alegre has authored 85 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cellular and Molecular Neuroscience, 47 papers in Neurology and 36 papers in Molecular Biology. Recurrent topics in Pedro Gonzalez‐Alegre's work include Genetic Neurodegenerative Diseases (49 papers), Neurological disorders and treatments (41 papers) and Mitochondrial Function and Pathology (15 papers). Pedro Gonzalez‐Alegre is often cited by papers focused on Genetic Neurodegenerative Diseases (49 papers), Neurological disorders and treatments (41 papers) and Mitochondrial Function and Pathology (15 papers). Pedro Gonzalez‐Alegre collaborates with scholars based in United States, Spain and France. Pedro Gonzalez‐Alegre's co-authors include Henry L. Paulson, Beverly L. Davidson, Adel K. Afifi, Michelle E. Ehrlich, Nicole M. Bode, Megan S. Keiser, Victor M. Miller, Tanya Bardakjian, Peg Nopoulos and Frederick L. Hitti and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Neuroscience.

In The Last Decade

Pedro Gonzalez‐Alegre

84 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Gonzalez‐Alegre United States 25 1.0k 953 827 292 152 85 2.0k
E Chabrol France 18 727 0.7× 673 0.7× 308 0.4× 154 0.5× 207 1.4× 28 1.6k
Ivelisse Sánchez Spain 20 1.2k 1.2× 979 1.0× 369 0.4× 98 0.3× 268 1.8× 31 1.9k
Puneet Opal United States 25 1.3k 1.3× 852 0.9× 426 0.5× 221 0.8× 568 3.7× 51 2.1k
Christopher R. Bye Australia 23 682 0.7× 508 0.5× 393 0.5× 96 0.3× 148 1.0× 31 1.8k
Andreas Weishaupt Germany 29 507 0.5× 1.1k 1.1× 1.5k 1.8× 116 0.4× 111 0.7× 58 2.7k
Teresia Osborn United States 15 1.3k 1.3× 671 0.7× 311 0.4× 102 0.3× 372 2.4× 18 1.9k
Hossein Darvish Iran 18 609 0.6× 270 0.3× 259 0.3× 332 1.1× 208 1.4× 96 1.3k
Nobutada Tachi Japan 16 789 0.8× 619 0.6× 234 0.3× 150 0.5× 148 1.0× 86 1.3k
Susan Maxwell United Kingdom 22 770 0.8× 274 0.3× 1.9k 2.3× 387 1.3× 431 2.8× 39 2.4k
Yuanyun Xie Canada 23 1.2k 1.2× 1.3k 1.4× 412 0.5× 123 0.4× 66 0.4× 39 2.0k

Countries citing papers authored by Pedro Gonzalez‐Alegre

Since Specialization
Citations

This map shows the geographic impact of Pedro Gonzalez‐Alegre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Gonzalez‐Alegre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Gonzalez‐Alegre more than expected).

Fields of papers citing papers by Pedro Gonzalez‐Alegre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Gonzalez‐Alegre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Gonzalez‐Alegre. The network helps show where Pedro Gonzalez‐Alegre may publish in the future.

Co-authorship network of co-authors of Pedro Gonzalez‐Alegre

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Gonzalez‐Alegre. A scholar is included among the top collaborators of Pedro Gonzalez‐Alegre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Gonzalez‐Alegre. Pedro Gonzalez‐Alegre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Fang, Qian Liu, Alex Mas Monteys, et al.. (2022). DeepRepeat: direct quantification of short tandem repeats on signal data from nanopore sequencing. Genome biology. 23(1). 108–108. 28 indexed citations
2.
Li, Fang, Alex Mas Monteys, Alexandra Dürr, et al.. (2022). Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing. Human Genetics and Genomics Advances. 4(1). 100146–100146. 10 indexed citations
3.
Creus‐Muncunill, Jordi, et al.. (2021). Striatal Cholinergic Dysregulation after Neonatal Decrease in X‐Linked Dystonia Parkinsonism‐Related TAF1 Isoforms. Movement Disorders. 36(12). 2780–2794. 10 indexed citations
4.
Guo, Michael H., Tanya Bardakjian, Steven S. Scherer, et al.. (2021). Temporal trends and yield of clinical diagnostic genetic testing in adult neurology. American Journal of Medical Genetics Part A. 185(10). 2922–2928. 13 indexed citations
5.
Bardakjian, Tanya, et al.. (2019). Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington’s Disease. Journal of Huntington s Disease. 8(1). 79–85. 7 indexed citations
6.
Gonzalez‐Alegre, Pedro. (2019). Advances in molecular and cell biology of dystonia: Focus on torsinA. Neurobiology of Disease. 127. 233–241. 23 indexed citations
7.
Zakirova, Zuchra, Tomas Fanutza, Ben Readhead, et al.. (2018). Mutations in THAP1/DYT6 reveal that diverse dystonia genes disrupt similar neuronal pathways and functions. PLoS Genetics. 14(1). e1007169–e1007169. 57 indexed citations
8.
Maguire, Jean Ann, Alyssa Gagne, Pedro Gonzalez‐Alegre, et al.. (2018). Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Research. 34. 101361–101361. 13 indexed citations
9.
Beauvais, Geneviève, Noela Rodríguez-Losada, Ying Lei, et al.. (2017). Exploring the Interaction Between eIF2α Dysregulation, Acute Endoplasmic Reticulum Stress and DYT1 Dystonia in the Mammalian Brain. Neuroscience. 371. 455–468. 28 indexed citations
10.
Lee, Jessica K., Yue Ding, Amy L. Conrad, et al.. (2016). Sex‐specific effects of the Huntington gene on normal neurodevelopment. Journal of Neuroscience Research. 95(1-2). 398–408. 37 indexed citations
11.
Beauvais, Geneviève, Nicole M. Bode, Hsiang Wen, et al.. (2016). Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1Knock-inMice Implicates Novel Pathways in Dystonia Pathogenesis. Journal of Neuroscience. 36(40). 10245–10256. 39 indexed citations
12.
Keiser, Megan S., Jeffrey H. Kordower, Pedro Gonzalez‐Alegre, & Beverly L. Davidson. (2015). Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy. Brain. 138(12). 3555–3566. 32 indexed citations
13.
Noetzli, Leila, Gary Brodsky, Jesse Hinckley, et al.. (2013). A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2. Gene. 533(1). 447–450. 9 indexed citations
14.
Bode, Nicole M., Cory A. Massey, & Pedro Gonzalez‐Alegre. (2012). DYT1 Knock-In Mice Are Not Sensitized against Mitochondrial Complex-II Inhibition. PLoS ONE. 7(8). e42644–e42644. 9 indexed citations
15.
Brown, Timothy, et al.. (2011). Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design. Gene Therapy. 18(7). 666–673. 83 indexed citations
16.
Glenn, Kevin A., et al.. (2010). Exploring the Influence of TorsinA Expression on Protein Quality Control. Neurochemical Research. 36(3). 452–459. 16 indexed citations
17.
Rodríguez-Lebrón, Edgardo & Pedro Gonzalez‐Alegre. (2006). Silencing neurodegenerative disease: bringing RNA interference to the clinic. Expert Review of Neurotherapeutics. 6(2). 223–233. 10 indexed citations
18.
Gonzalez‐Alegre, Pedro. (2006). Monomelic parkinsonian tremor caused by contralateral substantia nigra stroke. Parkinsonism & Related Disorders. 13(3). 182–184. 8 indexed citations
19.
Gonzalez‐Alegre, Pedro, Nicole M. Bode, Beverly L. Davidson, & Henry L. Paulson. (2005). Silencing Primary Dystonia: Lentiviral-Mediated RNA Interference Therapy for DYT1 Dystonia. Journal of Neuroscience. 25(45). 10502–10509. 76 indexed citations
20.
Gonzalez‐Alegre, Pedro, et al.. (2001). Increment of the Platelet Count in Temporal Arteritis: Response to Therapy and Ischemic Complications. European Neurology. 45(1). 43–45. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Chabrol Breakdown of academic impact, for papers by Ivelisse Sánchez Breakdown of academic impact, for papers by Puneet Opal Breakdown of academic impact, for papers by Christopher R. Bye Breakdown of academic impact, for papers by Andreas Weishaupt Breakdown of academic impact, for papers by Teresia Osborn Breakdown of academic impact, for papers by Hossein Darvish Breakdown of academic impact, for papers by Nobutada Tachi Breakdown of academic impact, for papers by Susan Maxwell Breakdown of academic impact, for papers by Yuanyun Xie
Rankless by CCL
2026